Cargando…

Mucosal immunity to poliovirus

A cornerstone of the global initiative to eradicate polio is the widespread use of live and inactivated poliovirus vaccines in extensive public health campaigns designed to prevent the development of paralytic disease and interrupt transmission of the virus. Central to these efforts is the goal of i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Connor, Ruth I., Brickley, Elizabeth B., Wieland-Alter, Wendy F., Ackerman, Margaret E., Weiner, Joshua A., Modlin, John F., Bandyopadhyay, Ananda S., Wright, Peter F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group US 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8732262/ https://www.ncbi.nlm.nih.gov/pubmed/34239028 http://dx.doi.org/10.1038/s41385-021-00428-0

Ejemplares similares

Vaccine-induced mucosal immunity to poliovirus: analysis of cohorts from an open-label, randomised controlled trial in Latin American infants
por: Wright, Peter F, et al.
Publicado: (2016)

Intestinal antibody responses to a live oral poliovirus vaccine challenge among adults previously immunized with inactivated polio vaccine in Sweden
por: Brickley, Elizabeth B, et al.
Publicado: (2019)

Intestinal Antibody Responses to 2 Novel Live Attenuated Type 2 Oral Poliovirus Vaccines in Healthy Adults in Belgium
por: Brickley, Elizabeth B, et al.
Publicado: (2020)

A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2020)

Intestinal Immunity to Poliovirus Following Sequential Trivalent Inactivated Polio Vaccine/Bivalent Oral Polio Vaccine and Trivalent Inactivated Polio Vaccine–only Immunization Schedules: Analysis of an Open-label, Randomized, Controlled Trial in Chilean Infants
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

Longitudinal Systemic and Mucosal Immune Responses to SARS-CoV-2 Infection( )
por: Wright, Peter F, et al.
Publicado: (2022)

Intestinal Immune Responses to Type 2 Oral Polio Vaccine (OPV) Challenge in Infants Previously Immunized With Bivalent OPV and Either High-Dose or Standard Inactivated Polio Vaccine
por: Brickley, Elizabeth B, et al.
Publicado: (2018)

Immunogenicity of New Primary Immunization Schedules With Inactivated Poliovirus Vaccine and Bivalent Oral Polio Vaccine for the Polio Endgame: A Review
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2018)

Distinct Features and Functions of Systemic and Mucosal Humoral Immunity Among SARS-CoV-2 Convalescent Individuals
por: Butler, Savannah E., et al.
Publicado: (2021)

Facility-Associated Release of Polioviruses into Communities—Risks for the Posteradication Era
por: Bandyopadhyay, Ananda S., et al.
Publicado: (2019)

Immunization Against Poliomyelitis and the Challenges to Worldwide Poliomyelitis Eradication
por: Modlin, John F, et al.
Publicado: (2021)

Triumphs of Immunization
por: Modlin, John F, et al.
Publicado: (2021)

Fecal Shedding of 2 Novel Live Attenuated Oral Poliovirus Type 2 Vaccine Candidates by Healthy Infants Administered Bivalent Oral Poliovirus Vaccine/Inactivated Poliovirus Vaccine: 2 Randomized Clinical Trials( )
por: Gast, Christopher, et al.
Publicado: (2021)

Protocol Paper: Oral Poliovirus Vaccine Transmissibility in Communities After Cessation of Routine Oral Poliovirus Vaccine Immunization
por: Sarnquist, Clea, et al.
Publicado: (2018)

Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine
por: Wright, Peter F., et al.
Publicado: (2016)

Does Simultaneous Administration of Bivalent (Types 1 and 3) Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine Induce Mucosal Cross-immunity to Poliovirus Type 2?
por: Resik, Sonia, et al.
Publicado: (2018)

A Review of the Most Commonly Used Methods for Sample Collection in Environmental Surveillance of Poliovirus
por: Matrajt, Graciela, et al.
Publicado: (2018)

Systematic Review of Mucosal Immunity Induced by Oral and Inactivated Poliovirus Vaccines against Virus Shedding following Oral Poliovirus Challenge
por: Hird, Thomas R., et al.
Publicado: (2012)

Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame
por: Parker, Edward PK, et al.
Publicado: (2015)

Reduced mucosal immunity to poliovirus after cessation of trivalent oral polio vaccine
por: Zhao, Ting, et al.
Publicado: (2021)

Human Circulating Antibody-Producing B Cell as a Predictive Measure of Mucosal Immunity to Poliovirus
por: Dey, Ayan, et al.
Publicado: (2016)

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials
por: Sáez-Llorens, Xavier, et al.
Publicado: (2021)

Safety and immunogenicity of inactivated poliovirus vaccine schedules for the post-eradication era: a randomised open-label, multicentre, phase 3, non-inferiority trial
por: Bandyopadhyay, Ananda S, et al.
Publicado: (2021)

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in healthy adults: two clinical trials
por: De Coster, Ilse, et al.
Publicado: (2021)

Systematic comparison of respiratory syncytial virus-induced memory B cell responses in two anatomical compartments
por: Shehata, Laila, et al.
Publicado: (2019)

Community transmission of type 2 poliovirus after cessation of trivalent oral polio vaccine in Bangladesh: an open-label cluster-randomised trial and modelling study
por: Taniuchi, Mami, et al.
Publicado: (2017)

Circulating Vaccine Derived Poliovirus and the polio eradication endgame
por: Davis, Robert, et al.
Publicado: (2012)

The Origins and Risk Factors for Serotype-2 Vaccine-Derived Poliovirus Emergences in Africa During 2016–2019
por: Gray, Elizabeth J, et al.
Publicado: (2023)

Boosting of Cross-Reactive Antibodies to Endemic Coronaviruses by SARS-CoV-2 Infection but not Vaccination with Stabilized Spike
por: Crowley, Andrew R., et al.
Publicado: (2021)

Boosting of cross-reactive antibodies to endemic coronaviruses by SARS-CoV-2 infection but not vaccination with stabilized spike
por: Crowley, Andrew R, et al.
Publicado: (2022)

The effect of maternal poliovirus antibodies on the immune responses of infants to poliovirus vaccines
por: Jia, Siyue, et al.
Publicado: (2020)

Notes from the Field: Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use — Six African Countries, 2021–2023
por: Davlantes, Elizabeth, et al.
Publicado: (2023)

Type 2 poliovirus detection after global withdrawal of trivalent oral vaccine
por: Blake, Isobel M., et al.
Publicado: (2018)

Deficiency of immunity to poliovirus type 3: a lurking danger?
por: Reinheimer, Claudia, et al.
Publicado: (2012)

The safety and immunogenicity of two novel live attenuated monovalent (serotype 2) oral poliovirus vaccines in healthy adults: a double-blind, single-centre phase 1 study
por: Van Damme, Pierre, et al.
Publicado: (2019)

The Duration of Intestinal Immunity After an Inactivated Poliovirus Vaccine Booster Dose in Children Immunized With Oral Vaccine: A Randomized Controlled Trial
por: John, Jacob, et al.
Publicado: (2017)

Exploring the relationship between polio type 2 serum neutralizing antibodies and intestinal immunity using data from two randomized controlled trials of new bOPV-IPV immunization schedules
por: Bandyopadhyay, Ananda S., et al.
Publicado: (2017)

Antibody Attributes that Predict the Neutralization and Effector Function of Polyclonal Responses to SARS-CoV-2
por: Natarajan, Harini, et al.
Publicado: (2021)

Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2
por: Natarajan, Harini, et al.
Publicado: (2022)

The differential impact of oral poliovirus vaccine formulation choices on serotype-specific population immunity to poliovirus transmission
por: Thompson, Kimberly M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_oe5ber514ud3viv2u8l5cn7aq2